EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Predictive Value of ALBI Score for No-Reflow in Non-ST Elevation Acute Coronary Syndrome

Abdullah Yildirim iD, Mukremin Coskun, Abdullah Orhan Demirtas iD

Journal of Clinical Medicine · 28.04.2025 · 14 (9) · 3035

DOI: 10.3390/jcm14093035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.04.2025. Verfasst von Abdullah Yildirim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Health Sciences, Adana City Training and Research Hospital, 01230 Adana, Türkiye. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The albumin–bilirubin (ALBI) score, initially a hepatic function marker, may also reflect systemic inflammation and oxidative stress, both linked to the no-reflow phenomenon (NRP). This study investigates the ALBI score’s predictive value for the NRP and compares it with conventional risk models.

Methods

This retrospective, single-center study included 1563 NSTE-ACS patients who underwent PCI between January 2023 and February 2024. Two predictive models were developed: (i) a fitted model with variables selected based on the XGBoost algorithm and SHapley Additive ExPlanations (SHAP) values, and (ii) an ALBI model including the ALBI score. Machine learning via the XGBoost algorithm was used for modeling, with SHAP applied to assess the significance of predictors.

Results

The NRP occurred in 14.8% (231/1563) of patients. The ALBI score emerged as an independent predictor (OR = 12.10, 95% CI: 7.75–18.89, p < 0.001). The ALBI model demonstrated superior predictive power compared to the fitted model (C-index: 0.860 vs. 0.799), with significant improvements in discrimination (11.1%, p < 0.001) and reclassification (14.5%, p = 0.002). SHAP analysis ranked the ALBI score (1.025) as the strongest predictor, followed by hs-TnI (0.814), e-GFR (0.582), and pre-dilatation (0.283). The ALBI model exhibited better specificity (AUC: 0.860 vs. 0.798), calibration (Brier score: 0.088 vs. 0.102), and model fit (AIC: 964.7 vs. 1098.3) compared to the fitted model, indicating superior overall performance.

Conclusions

The ALBI score significantly enhances the prediction of the NRP in NSTE-ACS patients undergoing PCI, outperforming traditional risk models. Incorporating the ALBI score into predictive frameworks may improve early risk stratification and guide clinical decision-making.

Schlagwörter

Stichwörter der Autor:innen

SHAP)albumin-bilirubin (ALBI) scoremachine learning (XGBoostno-reflow phenomenonnon-st elevation acute coronary syndromepercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, University of Health Sciences, Adana City Training and Research Hospital, 01230 Adana, Türkiye.

ORCID-Profile: Abdullah Yildirim, Abdullah Orhan Demirtas

Zitieren

APA

Yildirim, A., Coskun, M., & Demirtas, A. O. (2025). The Predictive Value of ALBI Score for No-Reflow in Non-ST Elevation Acute Coronary Syndrome. Journal of Clinical Medicine, 14(9), 3035. https://doi.org/10.3390/jcm14093035

Vancouver

Yildirim A, Coskun M, Demirtas AO. The Predictive Value of ALBI Score for No-Reflow in Non-ST Elevation Acute Coronary Syndrome. Journal of Clinical Medicine. 2025;14(9):3035. doi:10.3390/jcm14093035

BibTeX
@article{Yildirim2025,
  author = {Yildirim, Abdullah and Coskun, Mukremin and Demirtas, Abdullah Orhan},
  title = {The Predictive Value of ALBI Score for No-Reflow in Non-ST Elevation Acute Coronary Syndrome},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {3035},
  doi = {10.3390/jcm14093035}
}
Kostenlos starten →